Cytokinetics, Incorporated (FRA:KK3A)
63.00
+4.50 (7.69%)
At close: Dec 1, 2025
Cytokinetics Market Cap
Cytokinetics has a market cap or net worth of €6.95 billion as of December 1, 2025. Its market cap has increased by 11.15% in one year.
Market Cap
6.95B
Enterprise Value
7.28B
Revenue
74.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€63.00
Market Cap Chart
Since April 29, 2004, Cytokinetics's market cap has increased from 31.10M to 6.95B, an increase of 22,236.89%. That is a compound annual growth rate of 28.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 7.18B | 33.97% |
| Dec 31, 2024 | 5.36B | -27.60% |
| Dec 29, 2023 | 7.41B | 82.55% |
| Dec 30, 2022 | 4.06B | 20.68% |
| Dec 31, 2021 | 3.36B | 179.61% |
| Dec 31, 2020 | 1.20B | 114.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |